Birth control gel, first non-hormonal contraceptive option, gets FDA approval

The Print | May 23, 2020 at 6:11 AM
  • A new birth control gel is the first non-hormonal contraceptive to win FDA approval in decades, bringing another option to the $5.4 billion market.
  • The gel, marketed as Phexxi by Evofem Biosciences Inc., works by making pH levels in the vagina inhospitable to sperm when applied up to an hour before sex.
  • Currently approved hormonal products can trigger side effects like pain, nausea, headaches, bleeding, mood changes and weight gain.